These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4166403)

  • 21. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
    Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
    Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of immunoglobulins of external secretions in some paraproteinemic subjects].
    Cattaneo R; Mignone V; Rovati C
    Folia Allergol (Roma); 1967; 14(6):425-9. PubMed ID: 4171222
    [No Abstract]   [Full Text] [Related]  

  • 23. Production of common colds in human volunteers by influenza C virus.
    Joosting AC; Head B; Bynoe ML; Tyrrell DA
    Br Med J; 1968 Oct; 4(5624):153-4. PubMed ID: 5681050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunoglobulins of external secretions].
    Bazzi C; Balestrieri G; Rovati C; Besana C
    Folia Allergol (Roma); 1967; 14(6):385-8. PubMed ID: 4171216
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.
    Perkins JC; Tucker DN; Knope HL; Wenzel RP; Hornick RB; Kapikian AZ; Chanock RM
    Am J Epidemiol; 1969 Oct; 90(4):319-26. PubMed ID: 4309899
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections.
    Bellanti JA; Artenstein MS; Brandt BL; Klutinis BS; Buescher EL
    J Immunol; 1969 Nov; 103(5):891-8. PubMed ID: 4187116
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.
    Peterson KM; O'Shea M; Stam W; Mohede IC; Patrie JT; Hayden FG
    Antivir Ther; 2009; 14(1):33-43. PubMed ID: 19320235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds.
    Turner RB; Weingand KW; Yeh CH; Leedy DW
    Clin Infect Dis; 1998 Apr; 26(4):840-6. PubMed ID: 9564459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza virus neutralizing antibody in human respiratory secretions.
    Waldman RH; Mann JJ; Kasel JA
    J Immunol; 1968 Jan; 100(1):80-5. PubMed ID: 4169698
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rhinoviruses].
    Moisa I; Copelovici Y
    Stud Cercet Inframicrobiol; 1968; 19(2):131-50. PubMed ID: 4298909
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of illness from rhinovirus infection by a topical interferon inducer.
    Panusarn C; Stanley ED; Dirda V; Rubenis M; Jackson GG
    N Engl J Med; 1974 Jul; 291(2):57-61. PubMed ID: 4365144
    [No Abstract]   [Full Text] [Related]  

  • 32. Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine.
    Buscho RF; Perkins JC; Knopf HL; Kapikian AZ; Chanock RM
    J Immunol; 1972 Jan; 108(1):169-77. PubMed ID: 4334548
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of nasal secretion and serum antibody in the rhinovirus common cold.
    Cate TR; Rossen RD; Douglas RG; Butler WT; Couch RB
    Am J Epidemiol; 1966 Sep; 84(2):352-63. PubMed ID: 4288191
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of indirect immunofluorescence method for detection of rhinovirus-specific antibodies.
    Hrusková J; Strízová V; Syrŭcek L; Brûcková M
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(1):60-4. PubMed ID: 6262403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological stress and the common cold.
    Gwaltney JM; Hayden FG
    N Engl J Med; 1992 Feb; 326(9):644-5; author reply 645-6. PubMed ID: 1310349
    [No Abstract]   [Full Text] [Related]  

  • 36. Rhinovirus infection of vervet monkeys. A model of human rhinovirus disease.
    Martin GV; Heath RB
    Br J Exp Pathol; 1969 Oct; 50(5):516-9. PubMed ID: 4310539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of rhinovirus common colds in human voluteers.
    Douglas RG
    Ann Otol Rhinol Laryngol; 1970 Jun; 79(3):563-71. PubMed ID: 4316718
    [No Abstract]   [Full Text] [Related]  

  • 38. Duration of protection of calves against rhinovirus challenge exposure by infectious bovine rhinotracheitis virus-induced interferon in nasal secretions.
    MacLachlan NJ; Rosenquist BD
    Am J Vet Res; 1982 Feb; 43(2):289-93. PubMed ID: 6178325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The formation of interferon during acute respiratory virus infection of volunteers.
    Smorodintsev AA; Beare AS; Bynoe ML; Head B; Tyrrell DA
    Arch Gesamte Virusforsch; 1971; 33(1):9-16. PubMed ID: 4325979
    [No Abstract]   [Full Text] [Related]  

  • 40. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39.
    Alper CM; Doyle WJ; Skoner DP; Buchman CA; Seroky JT; Gwaltney JM; Cohen SA
    Laryngoscope; 1996 Oct; 106(10):1298-305. PubMed ID: 8849805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.